These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 26117661)
21. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. Yvan-Charvet L; Ranalletta M; Wang N; Han S; Terasaka N; Li R; Welch C; Tall AR J Clin Invest; 2007 Dec; 117(12):3900-8. PubMed ID: 17992262 [TBL] [Abstract][Full Text] [Related]
22. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812 [TBL] [Abstract][Full Text] [Related]
23. A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease. Kallend DG; Reijers JA; Bellibas SE; Bobillier A; Kempen H; Burggraaf J; Moerland M; Wijngaard PL Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):23-9. PubMed ID: 27418968 [TBL] [Abstract][Full Text] [Related]
24. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. Choi HY; Karten B; Chan T; Vance JE; Greer WL; Heidenreich RA; Garver WS; Francis GA J Biol Chem; 2003 Aug; 278(35):32569-77. PubMed ID: 12813037 [TBL] [Abstract][Full Text] [Related]
25. Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids. Duong M; Psaltis M; Rader DJ; Marchadier D; Barter PJ; Rye KA Biochemistry; 2003 Nov; 42(46):13778-85. PubMed ID: 14622025 [TBL] [Abstract][Full Text] [Related]
26. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro. Hafiane A; Bielicki JK; Johansson JO; Genest J PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756 [TBL] [Abstract][Full Text] [Related]
27. Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys. Kempen HJ; Gomaraschi M; Bellibas SE; Plassmann S; Zerler B; Collins HL; Adelman SJ; Calabresi L; Wijngaard PL J Lipid Res; 2013 Sep; 54(9):2341-53. PubMed ID: 23828780 [TBL] [Abstract][Full Text] [Related]
30. Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis. Cavigiolio G; Jayaraman S J Biol Chem; 2014 Apr; 289(14):10011-23. PubMed ID: 24523407 [TBL] [Abstract][Full Text] [Related]
31. Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux. Daniil G; Zannis VI; Chroni A PLoS One; 2013; 8(6):e67993. PubMed ID: 23826352 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms responsible for the compositional heterogeneity of nascent high density lipoprotein. Lund-Katz S; Lyssenko NN; Nickel M; Nguyen D; Chetty PS; Weibel G; Phillips MC J Biol Chem; 2013 Aug; 288(32):23150-60. PubMed ID: 23836906 [TBL] [Abstract][Full Text] [Related]
33. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. Yancey PG; de la Llera-Moya M; Swarnakar S; Monzo P; Klein SM; Connelly MA; Johnson WJ; Williams DL; Rothblat GH J Biol Chem; 2000 Nov; 275(47):36596-604. PubMed ID: 10964930 [TBL] [Abstract][Full Text] [Related]
34. A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice. Bielicki JK; Zhang H; Cortez Y; Zheng Y; Narayanaswami V; Patel A; Johansson J; Azhar S J Lipid Res; 2010 Jun; 51(6):1496-503. PubMed ID: 20075422 [TBL] [Abstract][Full Text] [Related]
35. Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I. Gkolfinopoulou C; Bourtsala A; Chroni A Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158593. PubMed ID: 31863971 [TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages. Brown BE; Nobecourt E; Zeng J; Jenkins AJ; Rye KA; Davies MJ PLoS One; 2013; 8(5):e65430. PubMed ID: 23741493 [TBL] [Abstract][Full Text] [Related]
37. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Li Q; Tsujita M; Yokoyama S Biochemistry; 1997 Oct; 36(40):12045-52. PubMed ID: 9315842 [TBL] [Abstract][Full Text] [Related]
38. An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice. Ditiatkovski M; D'Souza W; Kesani R; Chin-Dusting J; de Haan JB; Remaley A; Sviridov D PLoS One; 2013; 8(7):e68802. PubMed ID: 23874769 [TBL] [Abstract][Full Text] [Related]
39. ABCA1 (ATP-Binding Cassette Transporter A1) Mediates ApoA-I (Apolipoprotein A-I) and ApoA-I Mimetic Peptide Mobilization of Extracellular Cholesterol Microdomains Deposited by Macrophages. Jin X; Sviridov D; Liu Y; Vaisman B; Addadi L; Remaley AT; Kruth HS Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2283-2291. PubMed ID: 27758769 [TBL] [Abstract][Full Text] [Related]
40. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants. Sviridov D; Pyle LE; Fidge N J Biol Chem; 1996 Dec; 271(52):33277-83. PubMed ID: 8969186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]